Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Circ Heart Fail. 2017 Jun;10(6):e003940. doi: 10.1161/CIRCHEARTFAILURE.116.003940

Table 2.

HR (95% CI) for Heart Failure Hospitalization or Death by Pulmonary Hypertension Status in the Jackson Heart Study

Outcome Events
N (%)
Crude Model 1* Model 2
HR
(95% CI)
P-value HR
(95% CI)
P-value HR
(95% CI)
P-value
Heart failure hospitalization or death
• No pulmonary hypertension 52 (21) 1.0 (ref) 1.0 (ref) 1.0 (ref)
• Pulmonary hypertension present 28 (47) 2.19 (1.36, 3.53) 0.001 2.18 (1.20, 3.70) 0.003 1.84 (1.09, 3.10) 0.02
*

Model 1 adjusted for age, sex, diabetes mellitus, estimated glomerular filtration rate, and ejection fraction.

Model 2 adjusted for b-type natriuretic peptide in addition to covariates in model 1.

Because of missing data on heart failure hospitalization (N=106), the total N for this analysis is 302 (242 in the no PH group and 60 in the PH group). Please see method sections for more details.

HR, hazard ratio; CI, confidence interval.